Blog
RSS FeedPosted by Michael Wonder on 27 Mar 2023
TGA’s new powers will help reduce the impact of medicine shortages on patients
24 March 2023 - From 22 March 2023, the TGA can approve the temporary import or supply of an overseas approved ...
Posted by Michael Wonder on 27 Mar 2023
COVID-19 vaccine safety report (23 March 2023)
23 March 2023 - To 19 March 2023, more than 44 million doses have been administered in Australia, as well ...
Posted by Michael Wonder on 25 Mar 2023
Lapse of provisional registration for Tecentriq (atezolizumab) for the treatment of locally advanced or metastatic triple negative breast cancer
22 March 2023 - On 22 March 2023, the provisional registration of Tecentriq (atezolizumab) for the treatment of mTNBC will ...
Posted by Michael Wonder on 01 Mar 2023
Release of the Australian Government's response to the Review of COVID-19 Vaccine and Treatment Purchasing and Procurement
28 February 2023 - The Australian Government has responded to the Halton review into COVID-19 vaccine and treatment procurement. ...
Posted by Michael Wonder on 01 Mar 2023
ATAGI recommendations on use of the Moderna bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
28 February 2023 - Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) on the use of the Moderna bivalent ...
Posted by Michael Wonder on 28 Feb 2023
Supplies secured of latest Moderna COVID-19 vaccine as recommended by Halton Review
28 February 2023 - The Australian Government has secured an additional 3 million doses of the latest Moderna Omicron-specific COVID-19 vaccine ...
Posted by Michael Wonder on 23 Feb 2023
COVID-19 vaccine safety report (23 February 2023)
23 February 2023 - To 19 February 2023, over 44 million doses have been administered in Australia, as well as ...
Posted by Michael Wonder on 20 Feb 2023
TGA grants provisional approval to Moderna’s COVID-19 bivalent (Spikevax Bivalent Original/Omicron BA.4-5) booster dose vaccine
20 February 2023 - On 17 February, 2023, the TGA granted provisional approval to Moderna’s bivalent COVID-19 vaccine: elasomeran and ...
Posted by Michael Wonder on 09 Feb 2023
COVID-19 vaccine safety report (09 February 2023)
9 February 2023 - To 5 February 2023, over 44 million doses of Comirnaty have been administered in Australia, as well ...
Posted by Michael Wonder on 08 Feb 2023
ATAGI recommendations on use of the Pfizer bivalent (Original/Omicron BA.4/5) COVID-19 vaccine
8 February 2023 - On 20 January 2023, the TGA provisionally approved the Pfizer (Comirnaty) Bivalent Original/Omicron BA.4/5 vaccine for use ...
Posted by Michael Wonder on 08 Feb 2023
ATAGI 2023 booster advice
8 February 2023 - Recommendations from the Australian Technical Advisory Group on Immunisation (ATAGI) regarding COVID-19 boosters in 2023. ...
Posted by Michael Wonder on 02 Feb 2023
Professor John Skerritt retirement
2 February 2023 - Today, Professor John Skerritt has announced his decision to retire from his position of Deputy Secretary ...
Posted by Michael Wonder on 01 Feb 2023
Changes applying to evaluation of new substances for listed medicines
1 February 2023 - The TGA has introduced Mandatory requirements for applications to vary the Permissible Ingredients Determination under section 26BD ...
Posted by Michael Wonder on 30 Jan 2023
Life sciences industry calls for better funding for medicine and technology regulator
31 January 2023 - The life sciences, health and medicine sectors have come together to call for improved funding of ...
Posted by Michael Wonder on 29 Jan 2023
COVID-19 vaccine safety report (27 January 2023)
27 January 2023 - Since the beginning of the vaccine rollout to 22 January 2023, almost 65 million doses of COVID-19 ...